(Press-News.org) DALLAS - Jan. 25, 2021 - Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body's key cancer defenses, a new study led by UT Southwestern researchers suggests. The findings, reported online today in Cancer Research, a journal of the American Association for Cancer Research, could lead to new treatments for SCLC, which has no effective therapies.
Despite decades of study, SCLC - a subset of lung cancer that makes up about 13 percent of lung cancer diagnoses - has a very poor prognosis, with only about 6 percent of patients surviving five years after diagnosis. For the past 30 years, this disease has been treated with a combination of chemotherapies. Although most SCLC tumors initially respond to treatment, the majority of patients relapse within a year.
These tumors tend to carry many genetic mutations - often a good predictor of a strong immunotherapy response. However, says Esra Akbay, Ph.D., assistant professor of pathology and a member of the Harold C. Simmons Comprehensive Cancer Center at UTSW, immunotherapy drugs tend to not work well for SCLC patients, typically extending survival by just a few months.
"SCLC's inability to respond to immunotherapy made us think that there might be something about these tumors that allowed them to evolve to hide from the immune system," Akbay says. "We thought there might be defects in how these tumors communicate with immune cells that are supposed to recognize them as cancer."
To investigate this idea, Akbay and her colleagues looked at publicly available cancer datasets from patient tumors and data gathered from human tumor cell lines at UTSW to compare proteins on the surfaces of SCLC cells against non-small cell lung cancer (NSCLC) cells, which tend to respond better to immunotherapy. They quickly noticed that SCLC cells were missing the surface protein NKG2DL, which is known to interact with natural killer (NK) cells. NK cells make up a key part of the innate immune system, an evolutionary ancient part of the body's natural defense system that continually monitors for foreign invaders to launch an attack.
Data from mouse models of SCLC confirmed that the rodent version of NKG2DL was also missing from the surfaces of their cancer cells. When the researchers examined the animals' tumors, they found far fewer immune cells compared with those from mouse models of NSCLC. Additionally, the immune cells in the SCLC tumors weren't activated and therefore were unprepared to fight.
To better understand what role NKG2DL plays in SCLC immunity, Akbay and her colleagues genetically manipulated SCLC cell lines to force them to produce this protein on their surfaces. When they implanted these cells in mice, they grew smaller tumors and were less likely to spread. These tumors had a significantly higher population of immune cells than SCLC tumors that didn't express NKG2DL, and far more of the immune cells in tumors with NKG2DL were activated and ready to fight.
Akbay explains that some chemotherapy drugs can induce surface expression of NKG2DL; however, when she and her colleagues dosed SCLC cell lines with these medicines, they didn't prompt the cells to make this protein. Further investigation showed that the gene for NKG2DL wasn't mutated, suggesting that this protein was missing due to a problem with turning the gene on, rather than a faulty gene. Sure enough, further experiments showed that in SCLC cells, the gene responsible for making NKG2DL is hidden behind tightly coiled DNA, making it impossible for the cellular machinery that translates this gene into a protein to access it. When the researchers dosed animal models of SCLC with drugs called histone deacetylase (HDAC) inhibitors, which loosen DNA coils, the SCLC cells began expressing NKG2DL on their surfaces, translating into significantly smaller tumors that had more activated immune cells.
Turning again to a public cancer dataset, the researchers saw that neuroblastoma - one of the most common childhood cancers - is also typically missing NKG2DL on its cell surfaces. When the researchers dosed neuroblastoma cell lines with HDAC inhibitors, they also began expressing surface NKG2DL.
Together, Akbay says, these findings could lead to new ways to more accurately predict a patient's prognosis and guide better treatment choices for SCLC, neuroblastoma, and potentially other cancers. Patients whose tumor cell surfaces lack NKG2DL may have a more aggressive disease that is unlikely to respond to immunotherapy drugs, she explains. But the hope is that treatment with HDAC inhibitors may spur patients' immune systems to fight these tumors, enhancing immunotherapy effectiveness.
"The more we know about how the immune system interacts with cancer," Akbay says, "the more we can take advantage of the body's inherent defense system to fight this disease."
INFORMATION:
Other UTSW scientists who contributed to this study includefirst author and cancer biology Ph.D. student Mingrui Zhu, along with Yi Huang, Matthew E. Bender, Luc Girard, Rahul Kollipara, Buse Eglenen-Polat, Trisha K. Savage, Kenneth E. Huffman, John D. Minna, and Jane E. Johnson.
Akbay is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research. This work was supported by a CPRIT Scholar Award RR160080, National Institutes of Health grants CA070907, CA213338, and CA213274, and The Welch Foundation grant 1975-20190330. Dr. Minna receives licensing fees for the cell lines described in the manuscript.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty has received six Nobel Prizes, and includes 23 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.
Massive earthquakes are, fortunately, rare events. But that scarcity of information blinds us in some ways to their risks, especially when it comes to determining the risk for a specific location or structure.
"We haven't observed most of the possible events that could cause large damage," explained Kevin Milner, a computer scientist and seismology researcher at the Southern California Earthquake Center (SCEC) at the University of Southern California. "Using Southern California as an example, we haven't had a truly big earthquake since 1857 -- that was the last time the southern San Andreas broke into a massive magnitude ...
Scientists at Tokyo Institute of Technology (Tokyo Tech), Imperial and High Energy Accelerator Research Organization (KEK) Institute of Materials Structure Science, discover new Ba7Nb4MoO20-based materials with high oxygen-ion (oxide-ion O2-) conductivities--"the hexagonal perovskite-related oxides"--and shed light on the underlying mechanisms responsible for their conductivity. Their findings lead the way to uncovering other similar materials, furthering research on developing low-cost and scalable renewable energy technologies.
Over the past few years, fuel cells have become a focal point of research in eco-friendly technology because of their ...
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) have developed a new method to modify the spectral width of extreme-ultraviolet (XUV) light. By employing a novel phase-matching scheme in four-wave mixing, they could compress the spectral width of the initial broadband light by more than hundred times. The detailed experimental and theoretical results have been published in Nature Photonics.
Light, as emitted by the sun, consists of many different colors and typically appears as white. Sometimes, however, only certain colors reach our eyes, leading to stunning phenomena like an afterglow. For technical or scientific applications that require a specific color, gratings and prisms can be used to extract this color ...
What The Study Did: The results of this study suggest that cumulative exposure to cigarette smoke is an independent risk factor for hospital admission and death from COVID-19.
Authors: Katherine E. Lowe, M.Sc., of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve in Cleveland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2020.8360)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for ...
What The Study Did: The association of a shelter-in-place order with lower rates of seasonal respiratory viral activity was examined in this study.
Authors: Elizabeth Partridge, M.D., of the University of California at Davis School of Medicine in Sacramento, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.35281)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media ...
A study designed to study how the immune system impacts gut bacteria - has led to the extraordinary discovery of two molecules that can not only provide profound protection in experimental models of asthma but can also substantially reduce the severity of an attack.
Neither of these molecules, one of which is already commercially available as a dietary supplement, were previously known to have an effect on asthma - and they also appear, from animal studies, to have a role in treating the respiratory illness that is prevalent, and often fatal, in people with serious COVID-19.
The researchers aim to test one of the molecules in a clinical trial in 2021 in asthmatics.
As further evidence that these two molecules ...
As the planet's burden of rubber and plastic trash rises unabated, scientists increasingly look to the promise of closed-loop recycling to reduce waste. A team of researchers at Princeton's Department of Chemistry announces the discovery of a new polybutadiene molecule - from a material known for over a century and used to make common products like tires and shoes - that could one day advance this goal through depolymerization.
The Chirik lab reports in Nature Chemistry that during polymerization the molecule, named (1,n'-divinyl)oligocyclobutane, enchains in a repeating sequence of squares, a previously ...
Human females rely on aids like charting, test strips or wearable tech to identify periods of fertility. Some animals, like baboons, undergo obvious physical changes during ovulation. How did fertility become so hard to detect in humans?
For nearly half a century, the evolution of concealed ovulation in human females has been explained as useful for securing male partners to help raise and support children. A END ...
It was previously thought that collisions between galaxies would necessarily add to the activity of the massive black holes at their centers. However, researchers have performed the most accurate simulations of a range of collision scenarios and have found that some collisions can reduce the activity of their central black holes. The reason is that certain head-on collisions may in fact clear the galactic nuclei of the matter which would otherwise fuel the black holes contained within.
When you think about gargantuan phenomena such as the collision of galaxies, it might be tempting to imagine it as some sort of cosmic cataclysm, with stars crashing and exploding, and destruction on an epic scale. ...
New genetic faults discovered in people with a heart condition that is sometimes inherited in families could transform the diagnosis and treatment of the hidden disease, according to research funded by the British Heart Foundation (BHF) and published in Nature Genetics.
Researchers have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.
This ground-breaking discovery, which may be the biggest advance in our knowledge of the genetic basis of the ...
